| 2024-07-31 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | -470,00k | 0,00 | Verkauf | - | 33,70M | -1,38% |
| 2025-11-26 | Mr. Richard HoytIndependent Chairman | 93,56k | 0,00 | Acquisition Under Employee Benefit Plan | - | 402,56k | 30,28% |
| 2024-12-30 | John William-Richard EagleInsider | -6,40k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-11-26 | Dr. Julie StakiwChief Medical Officer | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 150,00k | 50,00% |
| 2025-11-26 | Mr. Scott William LivingstoneVP of Clinical Research | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,46 | 150,00k | 50,00% |
| 2025-11-26 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,46 | 743,11k | 50,70% |
| 2025-12-01 | Dr. Charlotte Moore HepburnIndependent Director | -41,06k | 0,00 | Derivative Exercise and Sale | 0,46 | 404,29k | - |
| 2025-11-26 | Mr. Keith CarpenterInsider | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 521,55k | 62,20% |
| 2025-11-26 | Mr. John M. HyshkaCFO | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 200,00k | - |